Tags: MDMAecstasyPTSD therapycare continuumcommunication
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Andrew Paul Popular Science Now on Bluesky America's Heartland | ||
| 2 | Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom | ||
| 3 | Judy George MedPage Today Medical reporter, writer. | Cardio Drugs and Dementia; Fampridine and Working Memory; Alzheimer's and Cancer - about 1 month ago | |
| 4 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Drugging the Undruggable - about 1 month ago | |
| 5 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | Spravato is just the beginning in a new wave of depression meds - about 1 month ago Neuro drugs are still faltering, despite rising investment - 5 months ago | |
| 6 | Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. | Drugmaker shut down after black schmutz found in injectable weight-loss drug - about 2 months ago | |
| 7 | Vox Staff Vox World explained. | Welcome to the Drug Issue of The Highlight - about 2 months ago | |
| 8 | Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois | More evidence on GLP-1s and opioid addiction - 2 months ago | |
| 9 | N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. | Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 3 months ago | |
| 10 | Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | What to Know About Delta-8 and Other Common Vape Shop Drugs - 4 months ago |